WeVote
Log In

Bill

RB

Bill

S 944

Expands epinephrine administration mechanisms permitted in schools, institutions of higher education, and youth camps.

2026-2027 Regular Session Introduced by Renee Burgess and 4 co-sponsors

New Jersey bill expands epinephrine administration methods in schools and youth facilities to enable faster emergency response to severe allergic reactions.

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
0
WeVote Research Nonpartisan
Bill Summary · S 944

Legislative bill overview

S 944 expands the methods by which epinephrine can be administered in schools, institutions of higher education, and youth camps in New Jersey. Rather than limiting administration to specific devices or protocols, the bill appears to broaden who can administer epinephrine and potentially how it can be delivered during allergic emergencies. This change aims to improve emergency response capabilities in youth-serving settings.

Why is this important

Anaphylaxis is a life-threatening allergic reaction that requires immediate epinephrine administration—delays of even minutes can be fatal. Schools and camps currently operate under specific regulatory frameworks that may restrict administration to trained personnel or certain devices. Expanding administration mechanisms could enable faster response times and potentially save lives by allowing more staff members to act during emergencies, or by permitting alternative delivery methods.

Potential points of contention

  • Training and liability concerns: Expanding who can administer epinephrine raises questions about required training levels, medical oversight, and institutional liability if administration is performed incorrectly
  • Regulatory clarity: The bill's scope depends heavily on how "expanded mechanisms" are defined—unclear language could create confusion about what methods are actually permitted
  • Device safety vs. accessibility trade-off: Broadening administration methods might include auto-injectors, pre-filled syringes, or other devices, each with different ease-of-use and error rates that regulators may want to evaluate differently

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.